✦ LIBER ✦

Discovery of SB-705498: A Potent, Selective and Orally Bioavailable TRPV1 Antagonist Suitable for Clinical Development.

✍ Scribed by Harshad K. Rami; et al. et al.

Publisher: John Wiley and Sons
Year: 2006
Weight: 10 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200638200

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery of INCB33

ChemInform Abstract: Discovery of INCB3344 (I), a Potent, Selective and Orally Bioavailable Antagonist of Human and Murine CCR2.

✍ Chu-Biao Xue; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of trans-N-[4- [2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl] -4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat.

✍ Geoffrey Stemp; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 1 views